Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
View/
Published Version
https://doi.org/10.1371/journal.pmed.1002196Metadata
Show full item recordCitation
Su, Mack Y., and David E. Fisher. 2016. “Immunotherapy in the Precision Medicine Era: Melanoma and Beyond.” PLoS Medicine 13 (12): e1002196. doi:10.1371/journal.pmed.1002196. http://dx.doi.org/10.1371/journal.pmed.1002196.Abstract
In a Perspective, Mack Su and David Fisher discuss the development of immunotherapies for treatment of melanoma and other cancer types.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154509/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:29739113
Collections
- FAS Scholarly Articles [18056]
- HMS Scholarly Articles [18305]
Contact administrator regarding this item (to report mistakes or request changes)